Press Releases electroCore, Inc.

Equities

ECOR

US28531P2020

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-01 pm EDT			5-day change	1st Jan Change
6.04 ^USD	-3.20%		+8.24%	+1.48%

Apr. 30	ElectroCore, Inc. Announces Results of Truvaga Plus Consumer Study	CI
Apr. 08	ElectroCore, Inc. Announces the Launch of Truvaga Plus® for General Wellness	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ElectroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024	08:05am	AQ
Truvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion	Apr. 30	AQ
ElectroCore Announces the Launch of Truvaga Plus® for General Wellness	Apr. 08	AQ
ElectroCore Expands Intellectual Property Portfolio	Apr. 02	AQ
ElectroCore Announces Fourth Quarter and Full Year 2023 Financial Results	Mar. 13	AQ
ElectroCore to Participate in Upcoming Investor Conferences	Mar. 12	AQ
ElectroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024	Mar. 05	AQ
ElectroCore Expands Intellectual Property Portfolio	Feb. 06	AQ
ElectroCore Expands Intellectual Property Portfolio	Jan. 09	AQ
ElectroCore Expands Intellectual Property Portfolio	Dec. 26	AQ
ElectroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology	Dec. 12	AQ
Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023	Nov. 15	AQ
ElectroCore Announces Third Quarter 2023 Financial Results	Nov. 08	AQ
ElectroCore to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum	Nov. 07	AQ
Data Highlighting Non-invasive Vagus Nerve Stimulation (nVNS) for Treatment of Symptoms of Gastroparesis Presented at 2023 American College of Gastroenterology Annual Meeting	23-10-24	AQ
ElectroCore Announces Two-Year Extension of gammaCore™ Device Listing in the NHS Supply Chain Catalogue	23-10-17	AQ
ElectroCore Expands Intellectual Property Portfolio for Non-Invasive Vagus Nerve Stimulation (nVNS) Technology	23-10-11	AQ
Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress	23-10-10	AQ
ElectroCore to Announce Third Quarter Financial Results on Wednesday, November 8	23-10-09	AQ
ElectroCore to Participate in the Lytham Partners Fall 2023 Virtual Investor Conference	23-10-05	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases electroCore, Inc.

Equities

ECOR

US28531P2020

Press Releases

Filters